SGD Pharma will launch My Sterinity Nasal at The DCAT (Drug, Chemical & Associated Technologies Association) Week 2026
We’re thrilled to showcase My Sterinity Nasal, which will be developed with Prince Sterilization Services.
This platform combines SGD Pharma’s Type I U-save vials with Prince’s RTU sterilization expertise, offering validated, ready-to-use packaging for high-value nasal therapies.
🧪 Controlled purity \| 🔬 Biologically inert Type I glass \| 💨 Compatible with preservative-free nasal pumps \| 📦 Double-bagged RTU formats
Produced at our plant of Saint Quentin La Motte (France), our Type I center of excellence, with a regional US supply chain, My Sterinity Nasal solution ensures stability, safety, and efficacy for sensitive nasal drug delivery, from acute to chronic therapies.
We can’t wait to see you at DCAT Week in New York!
Let’s connect from the 23rd to the 26th of March and explore how we can support your next projects.
📩 To schedule a meeting, please contact Marie-Christine.Revereausgdgroup.com
SGDPharma DCAT2026 TypeIGlass NasalDrugDelivery RTU PharmaceuticalPackaging Innovation